Blue Trust Inc’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Blue Trust Inc's ACLS Position: Q2 2026 in Review
Blue Trust Inc reduced its Axcelis (ACLS) stake by 85% in Q2 2026, selling an estimated $2.52K and leaving 3 shares worth $568. The position accounts for ﹤0.01% of the portfolio, ranked #2351.
Blue Trust Inc first reported a position in ACLS in Q2 2022 and has held it in 17 quarters since. The position peaked at $50K in Q4 2023. 439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Blue Trust Inc held 3 shares of Axcelis worth $568 as of Q2 2026.
- Blue Trust Inc sold 17 Axcelis shares in Q2 2026, an estimated $2.52K.
- Axcelis made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2351 holding.
- Blue Trust Inc first reported a position in Axcelis in Q2 2022 and has held it in 17 quarters since.
- Blue Trust Inc's Axcelis position peaked at $50K in Q4 2023.
- 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.